| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |